Area of research
Cancer Research · Surgery
Research interest
Research interests include Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Genomics and Diagnostics, Advanced Breast Cancer Therapies, and Cancer-related gene regulation.
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial
Abstract PR008: MYTHIC: First-in-human (FIH) biomarker-driven phase I trial of PKMYT1 inhibitor lunresertib (lunre) alone and with ATR inhibitor camonsertib (cam) in solid tumors with <i>CCNE1</i> amplification or deleterious alterations in <i>FBXW7</i> or <i>PPP2R1A</i>
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With <i>IDH1</i> Mutation
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study